| Cheminor |
 |
Over the years, we have moved up the value chain, leveraging our knowledge of
organic chemistry and skills in process development and process engineering, integrating forward into the manufacture
of finished dosages.
Today, Cheminor is one of the finest Global manufacturing organization with expertise on Process development , Bulk manufacturing, Formulations
development, Formulations manufacturing and Regulatory support thus giving it complete control on the supply chain and the ability to get to the market
faster. The integration of manufacturing operations positions us uniquely in the
regulated markets thus giving us the competitive edge of a lower cost position. Having met the most stringent regulatory requirements in the USA
and Europe, we have created a niche for ourselves in the highly regulated markets such as USA, Europe, Japan and Australia.
Strategic Locations
Our Corporate Headquarters are located in the Hyderabad, India.
We have subsidiaries in the USA - Reddy Cheminor Incorporated, Europe - Reddy Cheminor
S.A. in France and Singapore - Reddy Pharmaceuticals
Singapore Pte. Limited.
Key Strenghts
All our manufacturing facilities are designed and operated to comply with worldwide current good manufacturing practice
(cGMP) standards. Our
ceaseless systems orientation and regular internal checks ensure full validation
of methods, processes, equipment and product isolation in well contained clean rooms.
Cheminor has dedicated people for quality assurance at each facility monitored through a Corporate Quality Assurance team. They work as the internal audit
team with standards as demanding as those of the regulatory agencies ensuring high quality products are produced on a sustainable basis. Extensive
documentation and QA procedures are routinely practiced in all sites.
Competitive Cost Structure
One of the key strengths of Cheminor is its competitive cost structure. Cheminor's manufacturing infrastructure, process optimization skills, installed
capacities coupled with lower capital costs have resulted in a competitive cost position giving it an
edge to ensure success on a sustainable basis in the highly regulated markets.
Today for most of the products, Cheminor undertakes manufacturing from the basic stages.
Manufacturing operations and infrastructure is engineered to optimize solvent and by product recoveries resulting in high quality and lower
costs. Dedicated Scientific and engineering resources ensure continuous
process optimization.
World-class skills in process R & D
Our large pool of scientific talent has enabled us to develop processes for over
40 molecules in a short period of time. Availability of this scientific talent coupled with superior R&D skills have resulted in rapid process development
thereby reducing the product development time. Its fully equipped pilot plant facilities with sophisticated R & D infrastructure give it a competitive edge in its
Research & Development operations.
Safety Health & Environment norms
Environment protection is an integral part of Cheminor's business strategy. Being environmentally friendly is inter-linked with our business objectives.
The momentum of environment protection gave shape to a set of guidelines. The highlights of the guidelines are:
· Environment protection is a high priority goal and is a task for all.
· The impact of all Cheminor's operations on the environment is examined and
minimized before undertaking them.
· Cheminor emphasizes sustainable use of resources.
· Waste management is achieved by networking research and development,
production and waste treatment.
Scale of manufacturing operations
Cheminor has 3 bulk drug manufacturing facilities, two of which are USFDA inspected. The third facility is slated to be inspected shortly. Our infrastructure
consists of over 500 reactors with over 1.5 Mn liters of reaction volumes. Our sophisticated infrastructure is designed for a flexible product mix and ramping
up of production volumes to adapt to changing marketing requirement. Our new finished dosages facility has capabilities to manufacture tablets and
capsules-both hard and soft gelatins. This facility is designed to cater to regulated markets of USA, Europe, South Africa and Australia. This facility has
been recently inspected by the USFDA and MCC.
A vertically integrated organization
Vertically integrated pharmaceutical company with strengths in every aspect of the value chain. We have applied our strengths in process
development of bulk drugs to move up the value chain and target unique opportunities in the first world markets.
Capabilities in organic reactions
Our capabilities are reflected in the mastery of a wide range of organic chemical reactions. A few reactions among them are,
N-alkylation
O-Alkylation
Amidation
Cyanation
Cyclization
Darzen Glycidic Ester Synthesis
Diazotization
Friedel-Crafts acylation
Grignard reaction
Halogenation
High pressure and high temperature demethylation reaction.
|
